FSA Advisors
OTLK icon

FSA Advisors’s Outlook Therapeutics OTLK Stock Holding History

FSA Advisors’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.7K Buy
+16,898
New +$16.1K ﹤0.01% 263

Other funds holding OTLK

UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Gilpin Wealth Management
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Royal Fund Management
Royal Fund Management Lady Lake, Florida $1.26B AUM 23.83% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Christensen King & Associates Investment Services
Christensen King & Associates Investment Services Richland, Washington $276M AUM 13.14% 1-Year Est. Return
Flower City Capital
Flower City Capital Pittsford, New York $234M AUM 15.69% 1-Year Est. Return
Harbour Investments
Harbour Investments Madison, Wisconsin $6.75B AUM 16.25% 1-Year Est. Return

FSA Advisors's OTLK Position: Q3 2026 in Review

FSA Advisors opened a new position in Outlook Therapeutics (OTLK) in Q3 2026: 16,898 shares worth $9.7K. The stake represents ﹤0.01% of the portfolio and ranks #263 among its holdings.

38 funds tracked by Wall St. Rank hold OTLK as of Q3 2026.

  • FSA Advisors held 16,898 shares of Outlook Therapeutics worth $9.7K as of Q3 2026.
  • Outlook Therapeutics was a new FSA Advisors position in Q3 2026.
  • Outlook Therapeutics made up ﹤0.01% of FSA Advisors's portfolio in Q3 2026, its #263 holding.
  • 38 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2026.

Based on FSA Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.